FOCL Stock Summary and Trading Ideas (Edap Tms S.A. - American Depositary Shares Each Representing One Ordinary Share | NASDAQ:FOCL)

Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.

Edap Tms S.A. - American Depositary Shares Each Representing One Ordinary Share trades on the NASDAQ stock market under the symbol FOCL.

As of November 6, 2026, FOCL stock price declined to $3.32 with 355,429 million shares trading.

FOCL has a beta of 2.07, meaning it tends to be more sensitive to market movements. FOCL has a correlation of 0.10 to the broad based SPY ETF.

FOCL has a market cap of $152.56 million. This is considered a Micro Cap stock.

Last quarter Edap Tms S.A. - American Depositary Shares Each Representing One Ordinary Share reported $10 million in Revenue and -$.10 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.14.

FOCL support price is $4.05 and resistance is $4.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FOCL shares will trade within this expected range on the day.